Academy meeting examines the vaccine & avian influenza crisis

November 30, 2004

Effective vaccinations against influenza were established many years ago. However, lack of availability of vaccines and the potential for new influenza subtypes to spread in pandemics represent new challenges to global public health. To alleviate supply issues, some public health experts propose administering low-dose vaccines, but will this be adequate to protect high-risk populations? With the prospect of an avian influenza epidemic on the horizon, are researchers doing everything they can to create effective vaccines against this global health threat? How are scientists working to produce genetically modified vaccine strains and what are the results of vaccine evaluation in humans?

For many, it has become evident that strategies to improve the effectiveness of such vaccines are urgently needed.

To examine these and other controversial issues about the vaccine crisis and the science of producing effective vaccines against avian influenza, the New York Academy of Sciences is presenting a discussion, "The Science of Influenza Vaccines" on Thursday, December 2, from 5 to 7:30 p.m. at Academy headquarters, 2 East 63rd Street, New York, NY

The program will feature four speakers who will speak on the following topics:

  • "The Interferon Antagonist Gene of Influenza Virus as a Target for Attenuation in Live Influenza Vaccines."

    Speaker: Adolfo Garcia-Sastre, Mount Sinai School of Medicine

  • "Live Attenuated Influenza FluMist Vaccine: Genetic Studies of the Recently Drifted A/Fujian/411/2002-Like H3N2 Influenza Strains."

    Speaker: Hong Jin, MedImmune Vaccines

  • "Confronting the Challenge of Influenza."

    Speaker: John Treanor, University of Rochester Medical Center

  • "Vaccines for Avian Influenza Viruses with Pandemic Potential."

    Speaker: Jacqueline Katz, Centers for Disease Control and Prevention

    For further information, visit the meetings/conferences section of the web site. Space is limited. Please RSVP to Jennifer Tang at 212-838-0230 x257 or email to reserve a spot.
    Founded in 1817, the New York Academy of Sciences is an international organization of nearly 23,000 members worldwide dedicated to serving science, technology, and society.

    New York Academy of Sciences

    Related Influenza Articles from Brightsurf:

    Predicting influenza epidemics
    Researchers at Linköping University, Sweden, have developed a unique method to predict influenza epidemics by combining several sources of data.

    Common cold combats influenza
    As the flu season approaches, a strained public health system may have a surprising ally -- the common cold virus.

    Scent-sensing cells have a better way to fight influenza
    Smell receptors that line the nose get hit by Influenza B just like other cells, but they are able to clear the infection without dying.

    New antivirals for influenza and Zika
    Leuven researchers have deployed synthetic amyloids to trigger protein misfolding as a strategy to combat the influenza A and Zika virus.

    Assessment of deaths from COVID-19, seasonal influenza
    Publicly available data were used to analyze the number of deaths from seasonal influenza deaths compared with deaths from COVID-19.

    Obesity promotes virulence of influenza
    Obesity promotes the virulence of the influenza virus, according to a study conducted in mice published in mBio, an open-access journal of the American Society for Microbiology.

    Influenza: combating bacterial superinfection with the help of the microbiota
    Frenc researchers and from Brazilian (Belo Horizonte), Scottish (Glasgow) and Danish (Copenhagen) laboratories have shown for the first time in mice that perturbation of the gut microbiota caused by the influenza virus favours secondary bacterial superinfection.

    Chemists unveil the structure of an influenza B protein
    MIT chemists have discovered the structure of an influenza B protein called BM2, a finding that could help researchers design drugs that block the protein and help prevent the virus from spreading.

    How proteins help influenza A bind and slice its way to cells
    Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.

    Eating elderberries can help minimize influenza symptoms
    Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.

    Read More: Influenza News and Influenza Current Events
  • is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to